U-0126
(Synonyms: 1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯) 目录号 : GC45099A MEK inhibitor and AMPK activator
Cas No.:109511-58-2
Sample solution is provided at 25 µL, 10mM.
U-0126 is a MEK inhibitor with IC50 values of 72 nM and 58 nM for MEK1 and MEK2, respectively. [1] It is noncompetitive with respect adenosine triphosphate (ATP) and its phosphorylation target ERK and it shows little to no inhibition against a number of other kinases including PKC, Ab1, Raf, MEKK, ERK, JNK, MKK-3, MKK-4, MKK-6, Cdk2, and Cdk4. However, U-0126 does phosphorylate and activate AMP-activated protein kinase (AMPK) in a dose-dependent manner (EC50 = 15 µM in HEK293 cells).[2] It increases the ratios of ADP to ATP and AMP to ATP and increases phosphorylation of the AMPK target acetyl-CoA carboxylase (ACC).
U-0126是一种MEK抑制剂,其对MEK1和MEK2的IC50值分别为72 nM和58 nM。[1] 它在ATP和其磷酸化靶点ERK方面呈非竞争性,而且在其他许多激酶中几乎不表现出抑制作用,包括PKC、Ab1、Raf、MEKK、ERK、JNK、MKK-3、MKK-4、MKK-6、Cdk2和Cdk4。然而,U-0126以剂量依赖的方式在HEK293细胞中磷酸化并激活AMP-activated protein kinase(AMPK)(EC50 = 15μM)[2]。它增加了ADP / ATP和AMP / ATP比率,并增加了AMPK靶点乙酰辅酶A羧化酶(ACC)的磷酸化。
Reference:
[1]. Favata, M.F., Horiuchi, K.Y., Manos, E.J., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273(29), 18623-18632 (1998).
[2]. Dokladda, K., Green, K.A., Pan, D.A., et al. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett. 579(1), 236-240 (2005).
Cas No. | 109511-58-2 | SDF | |
别名 | 1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯 | ||
化学名 | 2,3-bis[amino[(2-aminophenyl)thio]methylene]-butanedinitrile | ||
Canonical SMILES | N/C(SC1=CC=CC=C1N)=C(C#N)\C(C#N)=C(N)\SC2=C(N)C=CC=C2 | ||
分子式 | C18H16N6S2 | 分子量 | 380.5 |
溶解度 | 0.5mg/mL in ethanol, 25mg/mL in DMSO, 30mg/mL in DMF | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.6281 mL | 13.1406 mL | 26.2812 mL |
5 mM | 0.5256 mL | 2.6281 mL | 5.2562 mL |
10 mM | 0.2628 mL | 1.3141 mL | 2.6281 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
LGG-s lost the improvement of barrier function after MEK inhibition.B–D IF staining and quantification of ZO-1, Occludin, and Claudin-1. Scale bar = 50 μm.
In the LPS +LGG-s + U0126 (MEKinhibitor,used at 10 μM, GlpBio, Montclair, CA, USA) group, the cells were pretreated with LGG-s at three concentration gradients (1:100, 1:50, and1:25) for 3 h, then treated with LPS and U0126 for 24 h.
Cell Death & Disease 14.1 (2023): 68. PMID: 36709322 IF: 9.6963 -
Related Biological Data
HCV core protein regulated the expression of PEA3 and SRF/c-Fos via the MAPK/ERK signaling pathway in liver cells. B. L02-Neo, L02-Core and Huh7-Core cells were treated with U0126 (0, 100 and 200 mmol) for 24 h.
In some experiments, cells were treated with 0, 100, and 200 mmol U0126 (ERK1/2 inhibitor; #GC45099, Glpbio, Montclair, CA, USA) for 24 h.
Archives of Medical Research (2022). PMID: 35817647 IF: 8.3235 -
Related Biological Data
Inhibition of the ERK signaling pathway attenuated IAA-mediated alleviation of colitis.A Western blot was conducted to confirm that the ERK inhibitor U0126 successfully inhibited the ERK pathway (E).
To demonstrate the influence of IAA on the ERK pathway,U0126 (GLPBIO) was intraperitoneally injected daily to inhibit ERK at a dose of 20 mg/kg.
Archives of Pharmacal Research (2024): 1-12. PMID: 38489148 IF: 6.7